156 related articles for article (PubMed ID: 37475123)
21. National adaptation and implementation of WHO Model List of Essential Medicines: A qualitative evidence synthesis.
Peacocke EF; Myhre SL; Foss HS; Gopinathan U
PLoS Med; 2022 Mar; 19(3):e1003944. PubMed ID: 35275938
[TBL] [Abstract][Full Text] [Related]
22. Use of evidence and negotiation in the review of national standard treatment guidelines and essential medicines list: experience from Ghana.
Koduah A; Asare BA; Gavor E; Gyansa-Lutterodt M; Andrews Annan E; Ofei FW
Health Policy Plan; 2019 Nov; 34(Supplement_2):ii104-ii120. PubMed ID: 31723963
[TBL] [Abstract][Full Text] [Related]
23. Global status of essential medicine selection: a systematic comparison of national essential medicine lists with recommendations by WHO.
Piggott T; Nowak A; Brignardello-Petersen R; Cooke GS; Huttner B; Schünemann HJ; Persaud N; Magrini N; Moja L
BMJ Open; 2022 Feb; 12(2):e053349. PubMed ID: 35144950
[TBL] [Abstract][Full Text] [Related]
24. WHO's essential medicines and AWaRe: recommendations on first- and second-choice antibiotics for empiric treatment of clinical infections.
Moja L; Zanichelli V; Mertz D; Gandra S; Cappello B; Cooke GS; Chuki P; Harbarth S; Pulcini C; Mendelson M; Tacconelli E; Ombajo LA; Chitatanga R; Zeng M; Imi M; Elias C; Ashorn P; Marata A; Paulin S; Muller A; Aidara-Kane A; Wi TE; Were WM; Tayler E; Figueras A; Da Silva CP; Van Weezenbeek C; Magrini N; Sharland M; Huttner B; Loeb M
Clin Microbiol Infect; 2024 Apr; 30 Suppl 2():S1-S51. PubMed ID: 38342438
[TBL] [Abstract][Full Text] [Related]
25. Selection of WHO-recommended essential medicines for non-communicable diseases on National Essential Medicines Lists.
Jarvis JD; Woods H; Bali A; Oronsaye E; Persaud N
PLoS One; 2019; 14(8):e0220781. PubMed ID: 31398195
[TBL] [Abstract][Full Text] [Related]
26. Essential Medicines at the National Level: The Global Asthma Network's Essential Asthma Medicines Survey 2014.
Bissell K; Ellwood P; Ellwood E; Chiang CY; Marks GB; El Sony A; Asher I; Billo N; Perrin C;
Int J Environ Res Public Health; 2019 Feb; 16(4):. PubMed ID: 30791442
[TBL] [Abstract][Full Text] [Related]
27. A quantitative comparison of essential cardiovascular medicines from countries in the Southern African Development Community to the WHO model essential medicines list.
Naicker I; Suleman F; Perumal-Pillay VA
J Pharm Policy Pract; 2022 Dec; 15(1):97. PubMed ID: 36482421
[TBL] [Abstract][Full Text] [Related]
28. The essential medicines list for a global patient population.
Robertson J; Hill SR
Clin Pharmacol Ther; 2007 Nov; 82(5):498-500. PubMed ID: 17952104
[TBL] [Abstract][Full Text] [Related]
29. Challenges in updating national guidelines and essential medicines lists in Sub-Saharan African countries to include WHO-recommended postpartum hemorrhage medicines.
Ng'ang'a J; Chitimbe T; Mburu R; Rushwan S; Ntirushwa D; Chinery L; Gülmezoglu AM
Int J Gynaecol Obstet; 2022 Jun; 158 Suppl 1(Suppl 1):11-13. PubMed ID: 35762803
[TBL] [Abstract][Full Text] [Related]
30. Social networks and health policy: the case of misoprostol and the WHO model essential medicine list.
Millard C; Brhlikova P; Pollock A
Soc Sci Med; 2015 May; 132():190-6. PubMed ID: 25818380
[TBL] [Abstract][Full Text] [Related]
31. Selection of essential medicines for South Africa - an analysis of in-depth interviews with national essential medicines list committee members.
Perumal-Pillay VA; Suleman F
BMC Health Serv Res; 2017 Jan; 17(1):17. PubMed ID: 28061899
[TBL] [Abstract][Full Text] [Related]
32. Essential medicines availability is still suboptimal in many countries: a scoping review.
Mahmić-Kaknjo M; Jeličić-Kadić A; Utrobičić A; Chan K; Bero L; Marušić A
J Clin Epidemiol; 2018 Jun; 98():41-52. PubMed ID: 29452222
[TBL] [Abstract][Full Text] [Related]
33. Essential Diagnostics for the Use of World Health Organization Essential Medicines.
Schroeder LF; Guarner J; Amukele TK
Clin Chem; 2018 Aug; 64(8):1148-1157. PubMed ID: 29871869
[TBL] [Abstract][Full Text] [Related]
34. Assessment of developmental risk information on medicines for inclusion on the WHO's Essential Medicines List.
Polifka JE; J Boroje I; Ferdosi H; Lamm SH
Int Health; 2019 Nov; 11(6):513-519. PubMed ID: 30916305
[TBL] [Abstract][Full Text] [Related]
35. Evaluating the implementation of the standard treatment guidelines (STGs) and essential medicines list (EML) at a public South African tertiary institution and its associated primary health care (PHC) facilities.
Govender T; Suleman F; Perumal-Pillay VA
J Pharm Policy Pract; 2021 Dec; 14(1):105. PubMed ID: 34906236
[TBL] [Abstract][Full Text] [Related]
36. Anticancer medicines in Pakistan: An analysis of essential medicines lists.
Shukar S; Anjum R; Zhang J; Babar ZU; Mobeen I; Yang C
J Oncol Pharm Pract; 2024 Jan; 30(1):46-54. PubMed ID: 37006130
[TBL] [Abstract][Full Text] [Related]
37. Burden of alcohol use and inclusion of alcohol use disorder medications in the essential medicine lists across 132 countries: An observational study.
Parmar A; Sahu DP; Behera P
Alcohol; 2024 Feb; ():. PubMed ID: 38423262
[TBL] [Abstract][Full Text] [Related]
38. Essential Medicines in a High Income Country: Essential to Whom?
Duong M; Moles RJ; Chaar B; Chen TF;
PLoS One; 2015; 10(12):e0143654. PubMed ID: 26650544
[TBL] [Abstract][Full Text] [Related]
39. Essential medicines lists for children of WHO, India, South Africa, and EML of China: A comparative study.
Liu D; Cheng J; Zhang LL; Li YP; Zeng LN; Zhang C; Gui G
J Evid Based Med; 2017 Nov; 10(4):271-280. PubMed ID: 28276634
[TBL] [Abstract][Full Text] [Related]
40. Rare essentials: drugs for rare diseases as essential medicines.
Stolk P; Willemen MJ; Leufkens HG
Bull World Health Organ; 2006 Sep; 84(9):745-51. PubMed ID: 17128345
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
